▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1396 by analyst upside · 2026-11-14
OABI
OmniAb, Inc.
Healthcare · Market Cap $716M · P/E 0x
ANALYST PRICE TARGET
+69.7%
implied upside to consensus target
Current Price $4.91
Consensus Target $8.33
Bull Target $12.0
Bear Target $5.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
6
Hold
0
Sell
0
52-Week Low $1.35
52-Week High $5.45
YTD Return +161.2%
FUNDAMENTALS
Market Cap $716M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.34
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $40M
Profit Margin -108.1%
52-WEEK RANGE
52-Week Low $1.35
52-Week High $5.45
Current Price $4.91
Bear Target $5.0
Bull Target $12.0
● Now $4.91 ● Target $8.33
TRADING DATA
Avg Volume 1.8M
YTD Return +161.2%
Analyst Count 6
Consensus Buy
Upside to Target +69.7%
Last Updated 2026-11-14

ANALYST SUMMARY

OmniAb, Inc. (OABI) is currently trading at $4.91 with a Wall Street consensus price target of $8.33, implying potential upside of 69.7% over the next 12 months. 6 analysts currently cover OABI, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $12.0, while the most cautious has a target of $5.0.

OABI operates in the Healthcare sector with a market capitalisation of $716M. The stock is up 161.2% year-to-date and is currently trading near the upper end of its 52-week range of $1.35 – $5.45.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for OABI, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Leerink Partners - Reiterated
Outperform → Outperform 2026-10-07 29% win rate (7 calls)
StoneX - Reiterated
Buy → Buy 2026-10-07 Building track record
HC Wainwright & Co. reit
Buy → Buy 2026-08-17 31% win rate (48 calls)
RBC Capital - Reiterated
Outperform → Outperform 2025-08-07 Building track record
Benchmark reit
Buy → Buy 2025-05-12 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2025-03-27 Building track record
Benchmark - Reiterated
Buy → Buy 2025-03-20 Building track record
HC Wainwright & Co. reit
Buy → Buy 2025-03-19 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
43
out of 100
Coverage depth
15/30
Consensus clarity
1/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →